Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease

K Matsushita, SH Ballew, AYM Wang… - Nature Reviews …, 2022 - nature.com
Chronic kidney disease (CKD) is defined by a low glomerular filtration rate or high
albuminuria, and affects 15–20% of adults globally. CKD increases the risk of various …

Primary stroke prevention worldwide: translating evidence into action

MO Owolabi, AG Thrift, A Mahal, M Ishida… - The Lancet Public …, 2022 - thelancet.com
Stroke is the second leading cause of death and the third leading cause of disability
worldwide and its burden is increasing rapidly in low-income and middle-income countries …

[HTML][HTML] Chlorthalidone vs. hydrochlorothiazide for hypertension–cardiovascular events

A Ishani, WC Cushman, SM Leatherman… - … England Journal of …, 2022 - Mass Medical Soc
Background Whether chlorthalidone is superior to hydrochlorothiazide for preventing major
adverse cardiovascular events in patients with hypertension is unclear. Methods In a …

The gut microbiome and hypertension

JA O'Donnell, T Zheng, G Meric… - Nature Reviews …, 2023 - nature.com
A large body of evidence has emerged in the past decade supporting a role for the gut
microbiome in the regulation of blood pressure. The field has moved from association to …

Reactive oxygen species scavenging nanomedicine for the treatment of ischemic heart disease

Z Zhang, R Dalan, Z Hu, JW Wang… - Advanced …, 2022 - Wiley Online Library
Ischemic heart disease (IHD) is the leading cause of disability and mortality worldwide.
Reactive oxygen species (ROS) have been shown to play key roles in the progression of …

Sex differences in arterial hypertension: a scientific statement from the ESC Council on Hypertension, the European Association of Preventive Cardiology, Association …

E Gerdts, I Sudano, S Brouwers, C Borghi… - European Heart …, 2022 - academic.oup.com
There is strong evidence that sex chromosomes and sex hormones influence blood
pressure (BP) regulation, distribution of cardiovascular (CV) risk factors and co-morbidities …

Effects of elevated systolic blood pressure on ischemic heart disease: a Burden of Proof study

C Razo, CA Welgan, CO Johnson, SA McLaughlin… - Nature medicine, 2022 - nature.com
High systolic blood pressure (SBP) is a major risk factor for ischemic heart disease (IHD), the
leading cause of death worldwide. Using data from published observational studies and …

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

MP Schlaich, M Bellet, MA Weber, P Danaietash… - The Lancet, 2022 - thelancet.com
Background Resistant hypertension is associated with increased cardiovascular risk. The
endothelin pathway has been implicated in the pathogenesis of hypertension, but it is …

Hypertension as cardiovascular risk factor in chronic kidney disease

M Burnier, A Damianaki - Circulation research, 2023 - Am Heart Assoc
Hypertension is the leading modifiable cause of premature death and hence one of the
global targets of World Health Organization for prevention. Hypertension also affects the …

Endovascular ultrasound renal denervation to treat hypertension: the RADIANCE II randomized clinical trial

M Azizi, M Saxena, Y Wang, JS Jenkins, C Devireddy… - Jama, 2023 - jamanetwork.com
Importance Two initial sham-controlled trials demonstrated that ultrasound renal denervation
decreases blood pressure (BP) in patients with mild to moderate hypertension and …